Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5542 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 45 46 47 ... 54 55 56  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Dr. Falk Pharma–Zedira: transglutaminase inhibitor, 2011– license to ZED1227 in Europe plus joint ownership of rights outside Europe 2011-01-01
iThera Medical–Germany (govt): grant, 2011 GO-Bio phase 2 grant from BMBF 2011-01-01
JnJ–Molecular Partners: DARPins, 2011–201610 collab + license DARPin targeting IL-13 + IL-17 against pulmonary disease TERMINATED 10/16 2011-01-01
MicroAQUA project–EU (govt): grant, 2011– FP7 grant to develop DNA microarray for water analysis 2011-01-01
MicroAQUA project–Scienion: DNA microarrays, 2011– collab Scienion is project member + final marketer of resulting DNA microarray for water analysis 2011-01-01
Pfizer–Kohlberg Kravis Roberts: investment, 2011 acquisition of Capsugel from Pfizer by KKR 2011-01-01
Select Biosciences–Alto Marketing: public relations, 2011– service public relations for European Lab Automation in Hamburg 2011 + 2012 2011-01-01
Springer–ASMS: Journal of the American Society for Mass Spectrometry, 2011– collab Springer to publish ASMS Journal before Elsevier 2011-01-01
Univ Bremen–Bruker Corp: mass spectrometer, 2011 supply autoflex speed LRF MALDI-TOF MS to new MALDI Imaging Lab 2011-01-01
Univ Cambridge–Agilent: mass spectrometer, 2011 supply Agilent 6460 Triple Quad MS with 1290 Infinity LC to Ralser Lab 2011-01-01
Univ Heidelberg–Bruker Corp: mass spectrometer, 2011c supply use of MALDI Biotyper at Univ Hospital Heidelberg 2011-01-01
Vita Diagnostika–Euro Diagnostica: investment, 2011 acquisition 2011-01-01
Xencor–Selexis: cell line development, 2011– supply service agreem for SUREtechnology for developm of multi-specific antibodies 2011-01-01
Cytonet–SEVERAL: investment, 201012 financing round €5.4m 2010-12-31
Hyglos–SEVERAL: investment, 201012 financing round €4.5m 2010-12-31
Cerilliant–Sigma-Aldrich: investment, 201012 acquisition €na of all outstanding shares 2010-12-30
MMT GmbH–Plan Optik: investment, 201012 acquisition of 70% majority share by Plan Optik 2010-12-27
Jacobs Univ–Bruker Corp: mass spectrometer, 201012 supply existent autoflex II MALDI-TOF at lab of Prof Nikolai Kuhnert 2010-12-22
Jacobs Univ–Bruker Corp: mass spectrometer, 201012 supply existent HCT ultra ion trap at lab of Prof Nikolai Kuhnert 2010-12-22
Jacobs Univ–Bruker Corp: mass spectrometer, 201012 supply existent micro TOFQ ESI at lab of Prof Nikolai Kuhnert 2010-12-22
Cevec–SEVERAL: investment, 201012 financing round €4.3m 1st closing 2010-12-21
Sigma ElectroOptics–Bruker Corp: investment, 201012 acquisition €na 2010-12-21
TKA Wasseraufbereitungssysteme–Thermo Fisher: investment, 201012 acquisition 2010-12-21
Nanohale–SEVERAL: investment, 201012 IPO €4.35m at Frankfurt Stock Exchange 2010-12-20
Novimmune–SEVERAL: investment, 201012 financing round Series B CHF20m led by BZ Bank AG 2010-12-17
Wilex–Hopp Group: credit, 201012– subordinated loan up to €7.5m interest rate 6% annual from Dievini Hopp BioTech Holding GmbH & Co KG 2010-12-17
Wilex–UCB: credit, 201012–201405 subordinated loan up to €2.5m interest rate 6% annual from UCB Pharma SA REPAYMENT WAIVED 5/14 2010-12-17
AstraZeneca–Evotec: antidiabetics, 201012– collab + license agreement €5m upfront + up to €254m milestones + royalties Develogen + MedImmune 2010-12-15
Nestlé–Novartis: investment, 201012–21104 acquisition of remaing shares of Alcon 2010-12-15
Merck (DE)–San Raffaele: drug development, 201012– collab strategic clinical research drugs for neurodegenerative diseases incl MS with Merck Serono 2010-12-13
Merck (DE)–San Raffaele: drug development, 201407– collab extension pre- + clinical research drugs for neurodegenerative diseases Merck Serono 2010-12-13
SciEngines–Schleswig-Holstein (govt): grant, 201012 grant €230k for development of Field Programmable Gate Arrays for bioinformatics 2010-12-09
Zweckverband Landeswasserversorgung–Danaher: mass spectrometer, 201012– supply AB Sciex TripleTOF 5600 to Waterworks Langenau + collab method developm 2010-12-08
SuppreMol–Germany (govt): grant, 201012– BMBF grant €1.6m to expand indications for SM101 as part of m4 Cluster initiative 2010-12-06
APHP–Bruker Corp: mass spectrometer, 201012– supply MALDI Biotyper as excl MALDI-TOF solution 3 new orders + 2 already used for years 2010-12-02
Dynacare–Bruker Corp: mass spectrometer, 201012 supply purchase of MALDI Biotyper as 5th clinical lab in US + 1st lab in Wisconsin 2010-12-02
HolsboerMaschmeyer Neurochemie–PERSON: investment, 201012 founding with Carsten Maschmeyer owning 50% 2010-12-02
HolsboerMaschmeyer Neurochemie–PERSON: investment, 201012 founding with Florian Holsboer owning 50% 2010-12-02
LZS-Concept–Bruker Corp: mass spectrometer, 201012 distribution existent in Austria by LZS-Concept GmbH 2010-12-02
ImaGenes–Source BioScience: investment, 201012 acquisition £2m in cash 2010-12-01
SuppreMol–SEVERAL: investment, 201012 financing round Series C €15.5m led by MIG AG w co-lead investor BioMedPartners 2010-12-01
Genzyme–Univ Konstanz: diagnostics, <201011 collab diagnosis of seldom genetic metabolic diseases Prof Michael Przybylski 2010-11-30
NN–Tecan: lab automation equipment, 201011– supply OEM fully automated instrument + plastic consumable to global diagnostics company 2010-11-30
United Nations–Qiagen: ESE-Quant Tube Scanner, 201011– inital supply of up to 50 instruments via Joint FAO/IAEA Program to emerging countries 2010-11-29
Merck (DE)–Evotec: drug discovery services, 201011– collab developm pre-clinical candidates for neurological disease within Neu² Consortium 2010-11-23
Biotype Diagnostic–Oxford Gene Technology: microarray technology, 201011– license to OGT patents for detection of DNA sequence variations 2010-11-22
Merck (DE)–Agilent: electronic lab notebook, 201011– supply €na ww use of Agilent OpenLAB ELN by approx 600 Merck-Serono biology researchers 2010-11-22
Ono Pharmaceutical–Paion: remimazolam, 201011 collab existent partnering CNS 7056 for developm in Japan with Ono 2010-11-22
Covaris–Tecan: automated sample preparation, 201011– collab co-marketing Freedom EVO with integrated Adaptive Focused Acoustics 2010-11-18
Univ Konstanz–Bruker Corp: mass spectrometer, 201011 supply existent Esquire 3000+ ion trap ESI-MS from Bruker Daltonik 2010-11-18
Actelion–Amgen: investment, 201011– RUMOURS OF possible acquisition offer by Amgen NO OFFER MADE YET 2010-11-17
Leukocare–SEVERAL: investment, 201011 financing round €1.6m capital increase with existent shareholders 2010-11-17
LeukoDx–thinXXS: microfluidics technology, 201011– supply developm of microfluidics cartridge by thinXXS for POC micro-flow cytometry system 2010-11-17
Siemens–Wilex: investment, 201011 acquisition assets of Oncogene Science business entity of Siemens Healthcare Diagnostics for €500k in cash 2010-11-17
BioGenes–b3c communications: public relations, 201011 service existent PR distribution via b3c newswire 2010-11-16
Graffinity–Novalix: investment, 201011– acquisition €na of majority interest by Novalix SAS 2010-11-16
Predictive Biosciences–Epigenomics: mGSTP1 biomarker, 201011– license non-excl extension €na for developm + sale of prostate cancer test 2010-11-16
SAW Instruments–Univ Konstanz: sam5 SAW biosensor, 201011 collab developm of bioaffinity-MS tandem ESI solution incl sam5 biosensor Prof Przybylski 2010-11-15
Delenex–SEVERAL: investment, 201011 financing round series A CHF13.5m (€10m) led by SVLS + HBM Bio + BioMedInvest + VI Partners 2010-11-12
Bavaria (govt)–Biocom: online marketing, 201011 supply service production Bio-M.TV 2010-11-10
Bavaria (govt)–Biocom: online marketing, 201011– production of Bio-M.TV for BioM by Biocom AG 2010-11-10
Micromet–SEVERAL: investment, 201011 public offering $72.3m net $70.5m 9.9m shares common stock $7.3/share 2010-11-10
Bruker Corp–Univ Göttingen: mass spectrometry, 201011 collab developm identification multicellular fungi with MALDI Biotyper Inst Medical Microbiology 2010-11-09
Caprotec–LBBW: investment, 201011 financing round Series B €1m 2nd closing with sole investor LBBW Venture Capital GmbH 2010-11-09
Univ Göttingen–Bruker Corp: mass spectrometer, 201011 supply MALDI Biotyper installed at Institute for Medical Microbiology at UMG 2010-11-09
mtm Laboratories–SEVERAL: investment, 201011 financing round addit tranche Series C €7m lead investors HBM + Wellington Partners + Gilde Healthcare 2010-11-08
Focus Clinical Drug Development–Adcuram: investment, 201011 acquisition of Focus by Nuvisan Group 2010-11-05
Biocartis–Mérieux: investment, 201011– equity investment 9€m in connection w strategic collaboration bioMérieux 2010-11-04
Biocrea–Biotie: investment, 201011 acquisition of minority position + funding of up to €4.8m by Biotie in management spin-out Biocrea 2010-11-04
Mérieux–Biocartis: molecular diagnostics, 201011–201311 strategic collab ww co-developm + marketing microbiol assays bioMérieux TERMINATED 11/13 2010-11-04
Hopp Group–Wilex: investment, 201011–2011Q1 acquisition €19.2m 100% of Heidelberg Pharma AG in shares by Wilex AG 2010-11-03
M-Scan–SGS: investment, 201011 acquisition 2010-11-01
PANOPTES project–EU (govt): grant, 201011–201410 FP7 funding €3.9m out of total project cost of €5.45m 2010-11-01
Q-Bioanalytic–Germany (govt): grant, 201011–201310 BMBF grant €264k for Q-Bionalytic GmbH within VibrioNet project 2010-11-01
Roche–DNA Electronics: DNA sequencing, 201011–201304 collab €na excl partnership + non-excl IP license for sequencing system DISSOLVED by Roche 4/13 2010-11-01
Techpool Bio-Pharma–Nycomed: investment, 201011 acquisition €na 51.34% replacing Shanghai Pharmaceutical Group as largest shareholder 2010-11-01
MeVis–Allianz: investment, 201010 existent Allianz Global Investors owns 3.3% of MeVis Medical Solutions AG 2010-10-31
MeVis–Fortelus: investment, 201010 existent Fortelus Special Situations Master Fund Ltd owns 10.8% of MeVis Medical Solutions AG 2010-10-31
MeVis–M.M. Warburg: investment, 201010 existent 10/10 MM Warburg & Co KG owns 6.4% of MeVis Medical Solutions AG 2010-10-31
MeVis–PERSON: investment, 201010 existent 10/10 Carl JG Evertz owns 19.5% of MeVis Medical Solutions AG 2010-10-31
MeVis–PERSON: investment, 201010 existent 10/10 Hartmut Jürgens owns 16.5% of MeVis Medical Solutions AG 2010-10-31
MeVis–PERSON: investment, 201010 existent 10/10 Heinz-Otto Peitgen owns 19.5% of MeVis Medical Solutions AG 2010-10-31
MeVis–PERSON: investment, 201010 existent 10/10 Peter Kuhlmann-Lehmkuhle owns 3% of MeVis Medical Solutions AG 2010-10-31
Evolva–COFRA: investment, 201010 existent Evolva listed as portfolio company of Entrepreneurs Fund 2010-10-28
Jingxin Pharmaceuticals–Evotec: EVT 201, 201010– collab + license excl for developm + marketing in China 2010-10-28
Protaffin–COFRA: investment, 201010 existent Protaffin listed as portfolio company of Entrepreneurs Fund 2010-10-28
Stellacure–COFRA: investment, 201010 existent Stellacure listed as portfolio company of Entrepreneurs Fund 2010-10-28
Apeiron–Evotec: drug discovery services, 201010– collab €na identification DREAM modulators for pain treatment 2010-10-27
Merck (DE)–Evotec: drug discovery services, 201010– collab developm HT screening assay for a MS target by European ScreeningPort within Neu² project 2010-10-27
biosyn–Panatecs: mass spectrometry services, 201010 collab developm protein quantification MS method for mistletoe lectin 2010-10-26
Boehringer–MacroGenics: antibody technology, 201010– collab global alliance to discovery + develop + commericalise DART antibody-based therapeutics 2010-10-26
Abunda Nutrition–Evolva: food ingredients, 201010– collab expansion + extension €na 2y research production methods for high-value food ingredients 2010-10-25
Lonza–Becton Dickinson: molecular diagnostics, 201010– collab excl license + ww co-marketing BD MAX System with microCompass for quality control 2010-10-25
Curefab–High-Tech Gründerfonds: investment, 201010 financing round led by HTGF + Bayern Kapital 2010-10-20
Curefab–SEVERAL: investment, 201010 financing round led by HTGF + Bayern Kapital 2010-10-20
Evotec–Hypha Discovery: MycoDiverse natural compound library, 201010– supply extension to collab to evaluate MycoDiverse against ESP assay panel 2010-10-19
Lundbeck–Paion: desmoteplase, 201010– collab expansion to incl ww excl rights for follow-on compounds incl €1.5m upfront payment 2010-10-15
Pronto Diagnostics–Epigenomics: molecular diagnostics, 201010– distribution excl Epi proColon test in Israel by Pronto Diagnostics 2010-10-14
United Kingdom (govt)–MorphoSys: research antibodies, 201010– supply AbD Serotec 2 year contract as preferred supplier for RCUK SSC Ltd 2010-10-14
Protagen–MicroDiscovery: biomarker discovery, 201010– collab combining MicroDiscovery software with Protagen UNIarray technology 2010-10-13
next pagenext page 1 2 3 ... 45 46 47 ... 54 55 56  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px

» top